122 related articles for article (PubMed ID: 20575024)
21. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
Alaminos M; Mora J; Cheung NK; Smith A; Qin J; Chen L; Gerald WL
Cancer Res; 2003 Aug; 63(15):4538-46. PubMed ID: 12907629
[TBL] [Abstract][Full Text] [Related]
22. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
23. Congenital neuroblastoma in a patient with partial trisomy of 2p.
Dowa Y; Yamamoto T; Abe Y; Kobayashi M; Hoshino R; Tanaka K; Aida N; Take H; Kato K; Tanaka Y; Ariyama J; Harada N; Matsumoto N; Kurosawa K
J Pediatr Hematol Oncol; 2006 Jun; 28(6):379-82. PubMed ID: 16794507
[TBL] [Abstract][Full Text] [Related]
24. The MYCN oncoprotein as a drug development target.
Lu X; Pearson A; Lunec J
Cancer Lett; 2003 Jul; 197(1-2):125-30. PubMed ID: 12880971
[TBL] [Abstract][Full Text] [Related]
25. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.
Fabris S; Mosca L; Cutrona G; Lionetti M; Agnelli L; Ciceri G; Barbieri M; Maura F; Matis S; Colombo M; Gentile M; Recchia AG; Anna Pesce E; Di Raimondo F; Musolino C; Gobbi M; Di Renzo N; Mauro FR; Brugiatelli M; Ilariucci F; Lipari MG; Angrilli F; Consoli U; Fragasso A; Molica S; Festini G; Vincelli I; Cortelezzi A; Federico M; Morabito F; Ferrarini M; Neri A
Am J Hematol; 2013 Jan; 88(1):24-31. PubMed ID: 23044996
[TBL] [Abstract][Full Text] [Related]
26. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.
Weniger MA; Pulford K; Gesk S; Ehrlich S; Banham AH; Lyne L; Martin-Subero JI; Siebert R; Dyer MJ; Möller P; Barth TF
Leukemia; 2006 Oct; 20(10):1880-2. PubMed ID: 16871282
[No Abstract] [Full Text] [Related]
27. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
28. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
29. MYCN oncoprotein targets and their therapeutic potential.
Bell E; Chen L; Liu T; Marshall GM; Lunec J; Tweddle DA
Cancer Lett; 2010 Jul; 293(2):144-57. PubMed ID: 20153925
[TBL] [Abstract][Full Text] [Related]
30. Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors.
Berbegall AP; Villamón E; Piqueras M; Tadeo I; Djos A; Ambros PF; Martinsson T; Ambros IM; Cañete A; Castel V; Navarro S; Noguera R
Oncogene; 2016 Mar; 35(11):1423-32. PubMed ID: 26119945
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of MYCN and ID2 overexpression in neuroblastoma.
Alaminos M; Gerald WL; Cheung NK
Pediatr Blood Cancer; 2005 Dec; 45(7):909-15. PubMed ID: 16047351
[TBL] [Abstract][Full Text] [Related]
32. t(14;18) and bcl-2 gene rearrangement in a B-chronic lymphocytic leukaemia.
Jonveaux P; Hillion J; Bennaceur AL; d'Agay MF; Brice P; Daniel MT; Sigaux F; Berger R
Br J Haematol; 1992 Aug; 81(4):620-1. PubMed ID: 1390255
[No Abstract] [Full Text] [Related]
33. Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
[TBL] [Abstract][Full Text] [Related]
34. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
[TBL] [Abstract][Full Text] [Related]
35. Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangement.
Jarosova M; Urbankova H; Plachy R; Papajik T; Holzerova M; Balcarkova J; Pikalova Z; Divoky V; Indrak K
Leuk Lymphoma; 2010 Feb; 51(2):304-13. PubMed ID: 20078324
[TBL] [Abstract][Full Text] [Related]
36. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
[TBL] [Abstract][Full Text] [Related]
37. Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN.
Bao J; Qin L; Cui L; Wang X; Meng Q; Zhu L; Zhang S
Mol Med Rep; 2015 Nov; 12(5):6867-72. PubMed ID: 26398570
[TBL] [Abstract][Full Text] [Related]
38. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
39. How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.
Maris JM
Pediatr Blood Cancer; 2005 Dec; 45(7):869-70. PubMed ID: 16206200
[No Abstract] [Full Text] [Related]
40. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ
Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
